Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

Celebrex receives approval in Mexico

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Synvisc relieves pain, delays need for total knee replacement in osteoarthritis

Feb. 12, 1999

Antiinflammatory/immunosuppressant agents acting on p38 MAP kinase designed at Novartis

Feb. 11, 1999

Fenamate-derived antiinflammatory agents in development at Abbott

Feb. 10, 1999

Subgroup-selective integrin binding inhibitors patented by Celltech

Feb. 5, 1999

New Celgene compounds reduceTNF-alpha levels and NF-kB activity

Feb. 5, 1999

Orthovisc introduced in Israel

Feb. 4, 1999

Proteasome inhibitors show potential in inflammatory disorders

Feb. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.